Soaring Demand Set to Propel Diabetic Retinopathy Market to $12.56 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Diabetic Retinopathy Market Through 2025?
The market size for diabetic retinopathy has seen significant growth in the past few years. The market, which stands at $8.61 billion in 2024, is projected to increase to $9.29 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%. This growth during the historic period can be linked to factors such as the growing elderly population, the rising instances of diabetes, greater awareness of diabetic retinopathy, enhanced healare infrastructure, and increased healare spending.

What's the Projected Size of the Global Diabetic Retinopathy Market by 2029?
The market size for diabetic retinopathy is projected to witness substantial growth in the coming years, reaching about $12.56 billion in 2029 with an annual compound growth rate (CAGR) of 7.8%. The anticipated growth is linked to factors such as personalized medicine approaches, broader telemedicine services, development of new therapeutic interventions, adoption of point-of-care testing, and remote patient monitoring. Key trends during this forecast period will include precise medicine for diabetic retinopathy treatment, a greater emphasis on early detection and prevention, an upward trend in teleophthalmology services, an increase in gene therapy research, and sustained improvements in retinal imaging technology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/diabetic-retinopathy-global-market-report

Top Growth Drivers in the Diabetic Retinopathy Industry: What's Accelerating the Market?
The escalating occurrence of diabetes is set to enhance the diabetic retinopathy market's expansion in the future. Diabetes is a persistent metabolic disorder leading to excessive glucose levels in the blood. Overweight, obesity, inheritance, and lack of physical exercise mainly prompt the surge in diabetes prevalence. In individuals with diabetes, there's an excess of sugar in the blood, potentially harmful to the retina, the part of the eye that detects light and transmits it to the brain through a nerve at the eye's back. For example, data from the Office for Health Improvement and Disparities, a UK government agency, revealed that the share of people with type 1 diabetes getting all eight suggested care processes rose by 22% from March 2022 to March 2023, while for those with type 2 diabetes, it was up by 21%. Furthermore, the percentage of people achieving target HbA1c levels reached a record 37.9% as per the National Diabetes Audit. Therefore, the escalating occurrence of diabetes boosts the diabetic retinopathy market's expansion.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12187&type=smp

What Trends Will Shape the Diabetic Retinopathy Market Through 2029 and Beyond?
A prominent trend emerging in the diabetic retinopathy market is the advent of technological advancements. To maintain their competitiveness, leading companies in the large volume parenteral market are turning to these new technologies. For example, Baxter International Inc., a healare firm based in the US, introduced the Welch Allyn RetinaVue 100 Imager PRO to South Korea in July 2022. These technological advancements are designed to facilitate the identification of diabetic retinopathy in primary healare environments. RetinaVue has been shown to enhance patient adherence to critically important annual diabetic retinal examinations (DREs) by enabling fast and comfortable screenings during regular primary care appointments.

What Are the Main Segments in the Diabetic Retinopathy Market?
The diabetic retinopathy market covered in this report is segmented -

1) By Type: Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy
2) By Treatment: Anti-VEGF Drugs, Intraocular Steroid Injection, Laser Photocoagulation, Vitreoretinal Surgery
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Proliferative Diabetic Retinopathy (PDR): Neovascularization, Vitreous Hemorrhage, Tractional Retinal Detachment
2) By Non-Proliferative Diabetic Retinopathy (NPDR): Mild NPDR, Moderate NPDR, Severe NPDR

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12187&type=smp

Which Top Companies are Driving Growth in the Diabetic Retinopathy Market?
Major companies operating in the diabetic retinopathy market include Pfizer Inc., F-Hoffmann-La Roche Ltd., Abbvie Inc., Bayer AG, Novartis AG, Ellex Medical Lasers Ltd., Abbott Laboratories Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Icon Bioscience Inc., Allergan plc., Genentech Inc., Aurobindo Pharma, Santen Pharmaceutical Co. Ltd., Carl Zeiss Meditec AG, Valeant Pharmaceuticals International Inc., Lumenis Ltd., Optos Plc., Quantel Medical SAS, NIDEK Co. Ltd., IRIDEX Corporation, Alimera Science Inc., Kowa Company Ltd., Ocular Therapeutix Inc., Aerpio Pharmaceuticals Inc., Kodiak Sciences Inc., Oxurion NV, Graybug Vision Inc., Ampio Pharmaceuticals Inc.

Which Regions Will Dominate the Diabetic Retinopathy Market Through 2029?
North America was the largest region in the diabetic retinopathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic retinopathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12187

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.